{"cik":1285550,"taxonomy":"us-gaap","tag":"AmortizationOfIntangibleAssets","label":"Amortization of Intangible Assets","description":"The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.","entityName":"ClearPoint Neuro, Inc.","units":{"USD":[{"start":"2024-01-01","end":"2024-12-31","val":0,"accn":"0001193125-26-111231","fy":2025,"fp":"FY","form":"10-K","filed":"2026-03-17","frame":"CY2024"},{"start":"2025-01-01","end":"2025-03-31","val":0,"accn":"0001193125-26-221890","fy":2026,"fp":"Q1","form":"10-Q","filed":"2026-05-13","frame":"CY2025Q1"},{"start":"2025-01-01","end":"2025-12-31","val":168000,"accn":"0001193125-26-111231","fy":2025,"fp":"FY","form":"10-K","filed":"2026-03-17","frame":"CY2025"},{"start":"2026-01-01","end":"2026-03-31","val":504000,"accn":"0001193125-26-221890","fy":2026,"fp":"Q1","form":"10-Q","filed":"2026-05-13","frame":"CY2026Q1"}]}}